Literature DB >> 21598385

Membrane proteomic signatures of karyotypically normal and abnormal human embryonic stem cell lines and derivatives.

Brian A Gerwe1, Peggi M Angel, Franklin D West, Kowser Hasneen, Amber Young, Ron Orlando, Steven L Stice.   

Abstract

Cultured human embryonic stem cells (hESCs) and derived derivatives contain heterogeneous cell populations with varying degrees of differentiation and karyotypic stability. The inability to isolate homogenous population presents a challenge toward cell-based applications and therapies. A proteomics approach was utilized to discover novel membrane proteins able to distinguish between the hESC lines BG01, WA09, and abBG02 (trisomy 12, 14, 17 and an extra copy of the X chromosome), along with WA09-derived human neural progenitor (hNP) cells. Membrane protein signatures were developed using sucrose-gradient isolation, 1-D gel electrophoresis followed by in-gel digestion and analysis by reverse phase chromatography coupled to ion trap-FT-ICR. At a ≤1.0% false discovery rate, 1918 proteins were identified; 775 were annotated as membrane proteins and 720 predicted to contain transmembrane spanning regions. Flow cytometry was used to validate cell surface expression of selected proteins. Junctional adhesion molecule 1 expression was shared by BG01, BG02 and abBG02 hESC lines. Dysferlin expression was specific to the WA09 hESC line and not the derived neural or mesenchymal progenitors. Ciliary neurotrophic factor receptor distinguished WA09-derived human neural progenitor cells from the parent hESC population, and WA09-derived mesenchymal progenitor cells. This study expands the current membrane protein data set for hESCs.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598385     DOI: 10.1002/pmic.201000032

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

1.  A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells.

Authors:  Rebekah L Gundry; Daniel R Riordon; Yelena Tarasova; Sandra Chuppa; Subarna Bhattacharya; Ondrej Juhasz; Olena Wiedemeier; Samuel Milanovich; Fallon K Noto; Irina Tchernyshyov; Kimberly Raginski; Damaris Bausch-Fluck; Hyun-Jin Tae; Shannon Marshall; Stephen A Duncan; Bernd Wollscheid; Robert P Wersto; Sridhar Rao; Jennifer E Van Eyk; Kenneth R Boheler
Journal:  Mol Cell Proteomics       Date:  2012-04-06       Impact factor: 5.911

Review 2.  The quest of cell surface markers for stem cell therapy.

Authors:  Anna Meyfour; Sara Pahlavan; Mehdi Mirzaei; Jeroen Krijgsveld; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Cell Mol Life Sci       Date:  2020-07-24       Impact factor: 9.261

3.  Isolation, genetic manipulation, and transplantation of canine spermatogonial stem cells: progress toward transgenesis through the male germ-line.

Authors:  Michael A Harkey; Atsushi Asano; Mary Ellen Zoulas; Beverly Torok-Storb; Jennifer Nagashima; Alexander Travis
Journal:  Reproduction       Date:  2013-06-14       Impact factor: 3.906

Review 4.  Potential for pharmacological manipulation of human embryonic stem cells.

Authors:  Stuart P Atkinson; Majlinda Lako; Lyle Armstrong
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  Identification of proteins related to epigenetic regulation in the malignant transformation of aberrant karyotypic human embryonic stem cells by quantitative proteomics.

Authors:  Yi Sun; Yixuan Yang; Sicong Zeng; Yueqiu Tan; Guangxiu Lu; Ge Lin
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.